Moleculin Biotech (MBRX) Profit After Tax (2016 - 2026)
Moleculin Biotech (MBRX) posted Profit After Tax of -$7.56 million for Q2 2026, compared with -$5.72 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Profit After Tax (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Profit After Tax at Moleculin Biotech was -$26.72 million; for FY2025, it was -$25.1 million.
- In prior years, Moleculin Biotech's Profit After Tax was -$26.64 million in FY2024, -$29.63 million in FY2023, -$30.64 million in FY2022 and -$22.97 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Profit After Tax since Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Moleculin Biotech | 34.08 Mn | 3.68 Mn | - | -7.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.56 Mn |
| Dec 31, 2025 | -7.53 Mn |
| Sep 30, 2025 | -5.91 Mn |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -5.94 Mn |
| Dec 31, 2024 | -6.64 Mn |
| Sep 30, 2024 | -7.14 Mn |
| Jun 30, 2024 | -6.19 Mn |
| Mar 31, 2024 | -6.68 Mn |
| Dec 31, 2023 | -8.92 Mn |
| Sep 30, 2023 | -5.95 Mn |
| Jun 30, 2023 | -6.41 Mn |
| Mar 31, 2023 | -8.35 Mn |
| Dec 31, 2022 | -7.05 Mn |
| Sep 30, 2022 | -9.08 Mn |
| Jun 30, 2022 | -7.43 Mn |
| Mar 31, 2022 | -7.07 Mn |
| Dec 31, 2021 | -5.21 Mn |
| Sep 30, 2021 | -6.16 Mn |
| Jun 30, 2021 | -5.52 Mn |
API Access
Moleculin Biotech Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();